BioMotiv

Bristol-Myers forms fibrotic disease biotech, bags buyout option
Fierce Biotech
Tue, 02/4/20 - 10:08 am
Bristol-Myers Squibb
BioMotiv
Anteros Pharmaceuticals
fibrotic disease
Bristol-Myers teams with BioMotiv to build and buy biotechs
Fierce Biotech
Wed, 09/4/19 - 10:25 am
Bristol-Myers Squibb
BioMotiv
M&A
biotech
BioMotiv, Rutgers launch TamRx
BioCentury
Sat, 02/9/19 - 12:28 pm
TamRx
BioMotiv
Rutgers
BioMotiv, Takeda Pharma enter into strategic partnership
PharmaBiz
Sat, 09/27/14 - 09:56 am
BioMotiv
Takeda
Takeda pours $25M into biotech dealmaker BioMotiv
Fierce Biotech
Fri, 09/26/14 - 12:03 pm
Takeda
BioMotiv
R&D
BioMotiv garners $46M for early-stage licensing deals, R&D work
Fierce Biotech
Mon, 08/5/13 - 01:46 pm
R&D
BioMotiv